Daily Ards Research Analysis

BACKGROUND: Acute respiratory distress syndrome (ARDS) induced by sepsis is a clinical syndrome characterized by high morbidity and mortality rates. This study aims to clarify the effects of recombinant mouse IL-27 protein on macrophage ferritinophagy, macrophage polarization, and its interventional role in sepsis-induced ARDS. METHODS: This study utilized wild-type (WT) and IL-27 receptor knockout (IL-27R RESULTS: This study investigates the role of IL-27 in exacerbating ferritinophagy and ferroptosis in macrophages and septic lung injury, and explores the therapeutic potential of the NCOA4 degrader CV3. We found that IL-27 synergizes with LPS to enhance NCOA4-mediated ferritinophagy, leading to increased degradation of FTH1, upregulation of LC3A/B, and promotion of ferroptosis. Ferritinophagy amplification drove M1 macrophage polarization and inflammatory cytokine release. CV3, a PROTAC-based NCOA4 degrader, effectively disrupted the NCOA4-FTH1 interaction, inhibited ferritinophagy, and mitigated ferroptosis and inflammation. In murine models of sepsis-induced ARDS, CV3 alleviated lung injury, restored antioxidant defenses, and reduced ferroptosis. Notably, IL-27R CONCLUSION: These findings reveal a potential mechanistic link between NCOA4-mediated ferritinophagy and sepsis-associated ARDS pathogenesis. Targeting this pathway with CV3 may offer a novel therapeutic strategy, which warrants further investigation.

BACKGROUND: Sepsis-associated acute respiratory distress syndrome (ARDS) is a severe condition characterized by high morbidity and mortality rates, necessitating effective therapeutic interventions. Ginsenoside Rg1 has been shown to ameliorate lung injury by targeting autophagy; however, the precise mechanisms involved remain to be elucidated. PURPOSE: The purpose of this research was to elucidate the therapeutic potential of ginsenoside Rg1 in mitigating ARDS by modulating autophagy and inhibiting apoptosis, inflammatory responses, and oxidative stress through the Prdx1-PTEN interaction. STUDY DESIGN: This experimental study adopted complementary in vivo and in vitro models. For the in vivo assays, C57BL/6 mice were randomly assigned to the sham operation group, cecal ligation and puncture (CLP)-induced sepsis group, and multiple-dose ginsenoside Rg1 intervention groups. Additionally, Prdx1 knockout mice were utilized for genetic validation. In the in vitro experiments, alveolar epithelial cells stimulated with lipopolysaccharide (LPS) were treated with graded concentrations of Rg1. Meanwhile, cell models with Prdx1 overexpression and knockout were established to identify the therapeutic target of Rg1. METHODS: The mechanistic effects of Rg1 on the Prdx1-PTEN interaction and its downstream signaling cascades were systematically investigated using an established murine model of sepsis induced by CLP, murine alveolar epithelial cells challenged with LPS, and genetically modified Prdx1 knockout mouse models. These complementary experimental systems were employed to dissect the molecular pathways mediating Rg1's therapeutic actions in sepsis-associated ARDS. RESULTS: Administration of Rg1 significantly enhanced the molecular interaction between Prdx1 and PTEN, and inhibited the PI3K/AKT signaling pathway, leading to increased autophagic activity and decreased apoptosis, inflammation, and oxidative stress in both in vivo and in vitro models of sepsis-induced acute lung injury. CONCLUSION: These results underscore the potential of Rg1 as a therapeutic option for sepsis-induced ARDS by targeting the Prdx1-PTEN interaction to enhance autophagy. Future clinical investigations are needed to explore the therapeutic application of Rg1 in sepsis-associated ARDS.

OBJECTIVE: Effective pressure management and comfort during prone positioning are core to improved ergonomics and patient tolerance, minimising the need for enhanced respiratory support techniques, such as mechanical ventilation. This study explored the impact of a new (low-tech) pillow solution on interface pressure and comfort during prone positioning compared with standard hospital solutions. METHOD: In this healthy patient cohort, within-subject, comparative study, person-surface interface pressures were measured for three different conscious prone positioning conditions: a standard hospital pillow at the head (HPO); a three-pillow standard hospital proning solution (HPP); and a new two-pillow prone positioning solution with additional standard head pillow (LPP). Contact surface area, peak and mean pressure, peak pressure index (PPI) (head, trunk, pelvis, legs), and subjective comfort were calculated for all conditions over a 21-minute period. RESULTS: The study cohort comprised 20 healthy volunteers. The LPP solution lowered PPI at the trunk compared to HPP (p<0.017) and HPO (p<0.001). The LPP solution also significantly reduced head PPI compared to lying with only a head support (p<0.002). Both HPP and LPP significantly improved comfort compared to proning with a head support only (both p<0.002). CONCLUSION: Overall, improved pressure management and comfort was noted for the alternative prone positioning kit, compared with existing solutions, suggesting a low-tech alternative to improving tolerance and adherence of patient prone positioning.